Pharma companies told to proactively develop monkeypox medication

Pharma companies told to proactively develop monkeypox medication hinh anh 1An antiviral drug for treatment (Photo: AFP/VNA)

Hanoi (VNA) – Facing
complex developments of the monkeypox outbreak in the world, the Health
Ministry’s Drug Administration has asked pharmaceutical and material producers to
increase the import of and proactively develop .

In a document sent on August
10, the agency requested the companies keep up with the development of monkeypox medication and vaccine in the world,
access drug material supply sources, and import materials into Vietnam to serve
drug development and production.

It also asked drug and
material importers to proactively liaise with foreign manufacturers to access
supply sources and survey demand among domestic health establishments.

The agency said it will
give maximum priority to licensing the circulation and importation of monkeypox
medication and drug materials in line with regulations.

Shortly after the World
Health Organisation (WHO) declared the monkeypox outbreak as a global
health emergency, the Ministry of Health issued guidance for monkeypox
diagnosis, treatment, and prevention.

New monkeypox infections have
been on the rise globally. Many countries have begun working to develop new and
more effective drugs for disease treatment.

Vietnam has not recorded any
monkeypox cases but there is still a risk that this disease will enter the
country./.

VNA

Source: VietnamPlus

Leave a Reply

Your email address will not be published. Required fields are marked *

14 Vu Trong Phung, Thanh Xuan, Ha Noi.

Hotline

Hotline

+84365999115

Email Us at

Email Us at

info@herac.org

Contact

Contact

Herac